Butylated Hydroxytoluene
CAS 128-37-0
Butylated Hydroxytoluene (CAS 128-37-0) is a Phase 2 pharmaceutical compound with 8 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 29272.714285714286 nM | 70 | - |
| - | IC50 | 18.726615384615382 ug.mL-1 | 39 | - |
| - | Potency | 33070.99545454545 nM | 21 | - |
| - | MIC | 105.73 ug.mL-1 | 9 | - |
| - | EC50 | 28800 nM | 5 | - |
| - | AC50 | 5055.633333333333 nM | 3 | - |
| - | EC50 | 24.25 ug.mL-1 | 2 | - |
| - | Ki | 630 nM | 1 | - |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| BHT | 1848 | SU | MTHSPL |
| BUTYLATED HYDROXYTOLUENE | 1848 | SU | MTHSPL |
| Butylated Hydroxytoluene | 1848 | SU | MTHSPL |
| Butylated hydroxytoluene | 1848 | SU | MTHSPL |
| butylated hydroxytoluene | 1848 | SU | MTHSPL |
| butylated hydroxytoluene | 1848 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Butylated Hydroxytoluene used for in pharmaceutical contexts?
Butylated Hydroxytoluene (CAS 128-37-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Butylated Hydroxytoluene?
No adverse-event association or SIDER side-effect rows are rendered for Butylated Hydroxytoluene in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Butylated Hydroxytoluene also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for BHT (Butylated Hydroxytoluene) with EU status "restricted".
What clinical phase is Butylated Hydroxytoluene in?
Butylated Hydroxytoluene is rendered with ChEMBL max phase 2.